PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
3028898-4	1987	Whereas the calcium-pentagastrin test provoked a markedly elevated plasma somatostatin level in association with a depressed plasma neurotensin level, the tolbutamide test surprisingly did not.	Pentagastrin	20-32	somatostatin	Homo sapiens	74-86	
9063035-4	1996	Intravenous injection of calcium followed by pentagastrin stimulates the release of somatostatin in patients with somatostatinoma and offers a reliable means for establishing the diagnosis of this tumor.	Pentagastrin	45-57	somatostatin	Homo sapiens	84-96	
2868953-0	1986	The effect of adding albumin to solutions of somatostatin (SST-14) on inhibiting pentagastrin-stimulated acid secretion in man.	Pentagastrin	81-93	somatostatin	Homo sapiens	45-57	
2868973-0	1986	Inhibition of pentagastrin-stimulated acid secretion after subcutaneous administration of a new somatostatin analogue.	Pentagastrin	14-26	somatostatin	Homo sapiens	96-108	
2868973-3	1986	We have therefore evaluated the effect of subcutaneous administration of a new synthetic somatostatin analogue, in comparison with a placebo, on pentagastrin stimulated acid secretion in six healthy volunteers.	Pentagastrin	145-157	somatostatin	Homo sapiens	89-101	
2868953-1	1986	The aim of this study was to identify the somatostatin (SST-14) dose dissolved in 0.1% human albumin solution equivalent to the commonly used therapeutic dose (3.5 micrograms kg-1 h-1) dissolved in saline in inhibiting pentagastrin-stimulated gastric acid secretion in healthy volunteers.	Pentagastrin	219-231	somatostatin	Homo sapiens	42-54	
6150888-0	1984	The effect of an octapeptide somatostatin analogue (SMS 201-995) and somatostatin-14 (SST-14) on pentagastrin-stimulated gastric acid secretion: a comparative study in man.	Pentagastrin	97-109	somatostatin	Homo sapiens	69-84	
6150888-0	1984	The effect of an octapeptide somatostatin analogue (SMS 201-995) and somatostatin-14 (SST-14) on pentagastrin-stimulated gastric acid secretion: a comparative study in man.	Pentagastrin	97-109	somatostatin	Homo sapiens	86-92	
6121709-2	1982	somatostatin on the gastric mucus output during a 60 min infusion of pentagastrin were examined in five healthy subjects.	Pentagastrin	69-81	somatostatin	Homo sapiens	0-12	
6133813-1	1983	The effects of 1 and 4 micrograms/kg/h somatostatin on pentagastrin-stimulated gastric mucosal blood flow and acid secretion were investigated in 12 normal subjects and in 12 patients with cirrhosis of the liver.	Pentagastrin	55-67	somatostatin	Homo sapiens	39-51	
6109275-2	1980	The ability of somatostatin to reduce splanchnic blood flow and portal pressure and to inhibit both gastrin release and the pentagastrin-stimulated secretion of gastric acid and pepsin provides its therapeutic use in multiple alimentary bleeding.	Pentagastrin	124-136	somatostatin	Homo sapiens	15-27	
647984-0	1978	Somatostatin inhibits the pentagastrin-induced release of serum calcitonin in medullary carcinoma of the thyroid.	Pentagastrin	26-38	somatostatin	Homo sapiens	0-12	
866987-0	1977	Inhibition by somatostatin of gastrin release and gastric acid responses to meals and to pentagastrin in man.	Pentagastrin	89-101	somatostatin	Homo sapiens	14-26	
866987-1	1977	The inhibitory actions of intravenous somatostatin on the gastric secretory responses to pentagastrin (1.5 microng/kg-h i.v.)	Pentagastrin	89-101	somatostatin	Homo sapiens	38-50	
866987-4	1977	Somatostatin (5 microng/kg-h; cyclic form) significantly inhibited the total 1-hour acid response to pentagastrin by about 70% (inhibition of pepsin secretion: about 70%) and that to a test meal by about 75%.	Pentagastrin	101-113	somatostatin	Homo sapiens	0-12	
866987-5	1977	During the last 30 min of somatostatin infusion the pentagastrin-stimulated secretion of acid was significantly reduced by about 90% (inhibition of pepsin output: about 85%) while the corresponding figure in the test with meal-induced secretion was about 95%.	Pentagastrin	52-64	somatostatin	Homo sapiens	26-38	
64051-2	1976	A direct inhibition of pentagastrin-stimulated acid secretion by somatostatin was demonstrated in three healthy volunteers and four patients with duodenal ulcer disease.	Pentagastrin	23-35	somatostatin	Homo sapiens	65-77